Easun Medical Officially Launches Operations in Changsha, Targeting Global Interventional Device Market

Release time:

2022-07-28

Author:

Source:


Abstract

Easun Medical enters the healthcare landscape with a clearly defined corporate mission: "Safeguard every heartbeat of life with dedication."

CHANGSHA, China – August 12, 2026 – Changsha EasunMT Medical Technology Co., Ltd., operating under the brand name Easun Medical, today announced its official commencement of operations in Changsha, Hunan Province. The company, founded in 2025, has completed its initial setup phase and is now fully engaged in the research, development, manufacturing, and marketing of interventional and implantable medical devices.
Easun Medical enters the healthcare landscape with a clearly defined corporate mission: "Safeguard every heartbeat of life with dedication." This guiding principle reflects the company's deep-rooted commitment to patient safety, clinical excellence, and the relentless pursuit of innovation in the medical device sector. The company positions itself as an innovative high-tech enterprise that integrates R&D, manufacturing, and marketing under one roof, enabling streamlined operations and faster time-to-market for critical medical technologies.
The interventional and implantable medical device market has witnessed substantial growth globally, driven by an aging population, rising prevalence of cardiovascular diseases, and increasing demand for minimally invasive procedures. Easun Medical aims to address these evolving needs by developing products that combine cutting-edge technology with cost-effectiveness. The company's corporate vision — "Committed to delivering cost-effective medical device products and services for patients and clinicians worldwide" — underscores its ambition to make advanced medical care accessible to a broader patient population across both developed and emerging markets.
"Easun Medical was founded on the belief that quality healthcare should not be a luxury," said a company spokesperson. "Our integrated approach allows us to maintain rigorous quality control while optimizing costs, ensuring that we can deliver products that meet the highest international standards at prices that healthcare systems can afford."
The company's three core values — Integrity, Compassion, and a dedication to innovation — form the ethical foundation of its operations. Integrity guides all business dealings, ensuring transparency and accountability. Compassion drives the company's patient-centric design philosophy, ensuring that every product is developed with the end-user's wellbeing in mind. These values are woven into the fabric of the organization, from the research laboratory to the manufacturing floor to the marketing team.
Easun Medical's headquarters in Changsha places the company in one of China's fastest-growing hubs for medical technology innovation. The city has invested heavily in life sciences infrastructure, and Easun Medical is poised to benefit from the region's rich talent pool, robust supply chain, and supportive policy environment for high-tech enterprises.
As the company embarks on its journey, it is actively building partnerships with research institutions, hospitals, and distribution networks to accelerate the development and deployment of its product pipeline. Further announcements regarding specific product launches and regulatory milestones are expected in the coming months.

Recommended Reading


Easun Medical Builds World-Class Team to Drive Innovation in Interventional and Implantable Medical Devices


Since its founding in 2025, Easun Medical has prioritized talent acquisition as a strategic imperative.

2026-08-12

Easun Medical Emphasizes Quality Management and Regulatory Compliance as Pillars of Corporate Integrity


For a medical device company, quality is not an optional extra — it is a fundamental obligation.

2026-08-12

Easun Medical Looks to the Future: A Roadmap for Global Impact in Interventional and Implantable Medical Devices


The company's roadmap is built on three strategic pillars: innovation, quality, and accessibility.

2026-08-12